论文部分内容阅读
AIM:To discuss treatment with eribulin in clinical practice outside a clinical trial.METHODS:Archives of patients treated for metastatic breast cancer were reviewed and 21 patients treated with the new chemotherapeutic eribulin mesylate,a synthetic analog